GO:0006370 | 7-methylguanosine mRNA capping | 5.96e-04 | 1.00e+00 | 5.762 | 2 | 5 | 24 |
GO:0050434 | positive regulation of viral transcription | 1.27e-03 | 1.00e+00 | 5.217 | 2 | 5 | 35 |
GO:0004832 | valine-tRNA ligase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 1.54e-03 | 1.00e+00 | 9.347 | 1 | 1 | 1 |
GO:0005739 | mitochondrion | 2.34e-03 | 1.00e+00 | 2.304 | 5 | 32 | 659 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 2.79e-03 | 1.00e+00 | 4.646 | 2 | 8 | 52 |
GO:0048742 | regulation of skeletal muscle fiber development | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0004647 | phosphoserine phosphatase activity | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0005846 | nuclear cap binding complex | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0002176 | male germ cell proliferation | 3.07e-03 | 1.00e+00 | 8.347 | 1 | 1 | 2 |
GO:0005850 | eukaryotic translation initiation factor 2 complex | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 2 | 3 |
GO:0006563 | L-serine metabolic process | 4.60e-03 | 1.00e+00 | 7.762 | 1 | 1 | 3 |
GO:0045292 | mRNA cis splicing, via spliceosome | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0006290 | pyrimidine dimer repair | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 2 | 4 |
GO:0006564 | L-serine biosynthetic process | 6.13e-03 | 1.00e+00 | 7.347 | 1 | 1 | 4 |
GO:0010467 | gene expression | 7.49e-03 | 1.00e+00 | 2.283 | 4 | 49 | 535 |
GO:0006282 | regulation of DNA repair | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 2 | 5 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 7.66e-03 | 1.00e+00 | 7.025 | 1 | 1 | 5 |
GO:0005654 | nucleoplasm | 8.04e-03 | 1.00e+00 | 1.894 | 5 | 68 | 876 |
GO:0050847 | progesterone receptor signaling pathway | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 1 | 6 |
GO:0001055 | RNA polymerase II activity | 9.18e-03 | 1.00e+00 | 6.762 | 1 | 3 | 6 |
GO:0002199 | zona pellucida receptor complex | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 4 | 7 |
GO:0000731 | DNA synthesis involved in DNA repair | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0006301 | postreplication repair | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 2 | 7 |
GO:0000339 | RNA cap binding | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 1 | 7 |
GO:0005832 | chaperonin-containing T-complex | 1.07e-02 | 1.00e+00 | 6.539 | 1 | 4 | 7 |
GO:0005829 | cytosol | 1.11e-02 | 1.00e+00 | 1.351 | 7 | 88 | 1787 |
GO:0005845 | mRNA cap binding complex | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0006450 | regulation of translational fidelity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 4 | 8 |
GO:0010225 | response to UV-C | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 2 | 9 |
GO:0006379 | mRNA cleavage | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 2 | 9 |
GO:0071354 | cellular response to interleukin-6 | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 1 | 9 |
GO:2000060 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.37e-02 | 1.00e+00 | 6.177 | 1 | 2 | 9 |
GO:0005736 | DNA-directed RNA polymerase I complex | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 1 | 10 |
GO:0001054 | RNA polymerase I activity | 1.53e-02 | 1.00e+00 | 6.025 | 1 | 4 | 10 |
GO:0000398 | mRNA splicing, via spliceosome | 1.60e-02 | 1.00e+00 | 3.347 | 2 | 15 | 128 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 4 | 11 |
GO:0008652 | cellular amino acid biosynthetic process | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 2 | 11 |
GO:0008334 | histone mRNA metabolic process | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 1 | 11 |
GO:0000266 | mitochondrial fission | 1.68e-02 | 1.00e+00 | 5.887 | 1 | 2 | 11 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 13 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.98e-02 | 1.00e+00 | 5.646 | 1 | 3 | 13 |
GO:0006386 | termination of RNA polymerase III transcription | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 3 | 14 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 3 | 14 |
GO:0016575 | histone deacetylation | 2.13e-02 | 1.00e+00 | 5.539 | 1 | 2 | 14 |
GO:0008135 | translation factor activity, nucleic acid binding | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 4 | 15 |
GO:0000188 | inactivation of MAPK activity | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 1 | 15 |
GO:0007339 | binding of sperm to zona pellucida | 2.28e-02 | 1.00e+00 | 5.440 | 1 | 4 | 15 |
GO:0003887 | DNA-directed DNA polymerase activity | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 2 | 16 |
GO:0009060 | aerobic respiration | 2.43e-02 | 1.00e+00 | 5.347 | 1 | 1 | 16 |
GO:0008380 | RNA splicing | 2.58e-02 | 1.00e+00 | 2.980 | 2 | 21 | 165 |
GO:0031667 | response to nutrient levels | 2.58e-02 | 1.00e+00 | 5.259 | 1 | 2 | 17 |
GO:0005737 | cytoplasm | 2.71e-02 | 1.00e+00 | 0.984 | 8 | 127 | 2633 |
GO:0003899 | DNA-directed RNA polymerase activity | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 3 | 18 |
GO:0031047 | gene silencing by RNA | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 2 | 18 |
GO:0033574 | response to testosterone | 2.73e-02 | 1.00e+00 | 5.177 | 1 | 1 | 18 |
GO:0004842 | ubiquitin-protein transferase activity | 3.00e-02 | 1.00e+00 | 2.863 | 2 | 17 | 179 |
GO:0006913 | nucleocytoplasmic transport | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0034080 | CENP-A containing nucleosome assembly | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0071897 | DNA biosynthetic process | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 2 | 20 |
GO:0034660 | ncRNA metabolic process | 3.03e-02 | 1.00e+00 | 5.025 | 1 | 1 | 20 |
GO:0051084 | 'de novo' posttranslational protein folding | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 4 | 22 |
GO:0000387 | spliceosomal snRNP assembly | 3.33e-02 | 1.00e+00 | 4.887 | 1 | 1 | 22 |
GO:0008180 | COP9 signalosome | 3.63e-02 | 1.00e+00 | 4.762 | 1 | 6 | 24 |
GO:0006281 | DNA repair | 3.78e-02 | 1.00e+00 | 2.681 | 2 | 24 | 203 |
GO:0009267 | cellular response to starvation | 3.92e-02 | 1.00e+00 | 4.646 | 1 | 1 | 26 |
GO:0006360 | transcription from RNA polymerase I promoter | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 4 | 27 |
GO:0007005 | mitochondrion organization | 4.22e-02 | 1.00e+00 | 4.539 | 1 | 2 | 28 |
GO:0006418 | tRNA aminoacylation for protein translation | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 6 | 29 |
GO:0006446 | regulation of translational initiation | 4.37e-02 | 1.00e+00 | 4.489 | 1 | 2 | 29 |
GO:0045111 | intermediate filament cytoskeleton | 4.66e-02 | 1.00e+00 | 4.392 | 1 | 3 | 31 |
GO:0007254 | JNK cascade | 5.10e-02 | 1.00e+00 | 4.259 | 1 | 1 | 34 |
GO:0031124 | mRNA 3'-end processing | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 4 | 35 |
GO:0044297 | cell body | 5.25e-02 | 1.00e+00 | 4.217 | 1 | 5 | 35 |
GO:0003723 | RNA binding | 5.39e-02 | 1.00e+00 | 2.398 | 2 | 22 | 247 |
GO:0003743 | translation initiation factor activity | 5.54e-02 | 1.00e+00 | 4.137 | 1 | 8 | 37 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 5.68e-02 | 1.00e+00 | 4.099 | 1 | 4 | 38 |
GO:0006369 | termination of RNA polymerase II transcription | 5.68e-02 | 1.00e+00 | 4.099 | 1 | 5 | 38 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 5.98e-02 | 1.00e+00 | 4.025 | 1 | 6 | 40 |
GO:0000775 | chromosome, centromeric region | 6.12e-02 | 1.00e+00 | 3.989 | 1 | 6 | 41 |
GO:0003684 | damaged DNA binding | 6.12e-02 | 1.00e+00 | 3.989 | 1 | 1 | 41 |
GO:0006406 | mRNA export from nucleus | 6.55e-02 | 1.00e+00 | 3.887 | 1 | 7 | 44 |
GO:0009612 | response to mechanical stimulus | 6.84e-02 | 1.00e+00 | 3.823 | 1 | 2 | 46 |
GO:0032481 | positive regulation of type I interferon production | 7.13e-02 | 1.00e+00 | 3.762 | 1 | 3 | 48 |
GO:0006334 | nucleosome assembly | 7.56e-02 | 1.00e+00 | 3.674 | 1 | 4 | 51 |
GO:0006289 | nucleotide-excision repair | 7.84e-02 | 1.00e+00 | 3.619 | 1 | 6 | 53 |
GO:0016311 | dephosphorylation | 8.13e-02 | 1.00e+00 | 3.565 | 1 | 3 | 55 |
GO:0008584 | male gonad development | 8.41e-02 | 1.00e+00 | 3.514 | 1 | 1 | 57 |
GO:0042826 | histone deacetylase binding | 8.55e-02 | 1.00e+00 | 3.489 | 1 | 5 | 58 |
GO:0006464 | cellular protein modification process | 8.98e-02 | 1.00e+00 | 3.416 | 1 | 4 | 61 |
GO:0030018 | Z disc | 9.40e-02 | 1.00e+00 | 3.347 | 1 | 3 | 64 |
GO:0006366 | transcription from RNA polymerase II promoter | 9.47e-02 | 1.00e+00 | 1.933 | 2 | 23 | 341 |
GO:0044267 | cellular protein metabolic process | 9.99e-02 | 1.00e+00 | 1.887 | 2 | 14 | 352 |
GO:0030308 | negative regulation of cell growth | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 3 | 70 |
GO:0051082 | unfolded protein binding | 1.02e-01 | 1.00e+00 | 3.217 | 1 | 5 | 70 |
GO:0001649 | osteoblast differentiation | 1.08e-01 | 1.00e+00 | 3.137 | 1 | 5 | 74 |
GO:0030529 | ribonucleoprotein complex | 1.19e-01 | 1.00e+00 | 2.989 | 1 | 5 | 82 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.22e-01 | 1.00e+00 | 2.954 | 1 | 5 | 84 |
GO:0000209 | protein polyubiquitination | 1.32e-01 | 1.00e+00 | 2.823 | 1 | 6 | 92 |
GO:0006511 | ubiquitin-dependent protein catabolic process | 1.32e-01 | 1.00e+00 | 2.823 | 1 | 6 | 92 |
GO:0006260 | DNA replication | 1.35e-01 | 1.00e+00 | 2.792 | 1 | 9 | 94 |
GO:0016032 | viral process | 1.38e-01 | 1.00e+00 | 1.605 | 2 | 30 | 428 |
GO:0006457 | protein folding | 1.39e-01 | 1.00e+00 | 2.747 | 1 | 5 | 97 |
GO:0006413 | translational initiation | 1.42e-01 | 1.00e+00 | 2.717 | 1 | 6 | 99 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.50e-01 | 1.00e+00 | 2.632 | 1 | 5 | 105 |
GO:0042981 | regulation of apoptotic process | 1.59e-01 | 1.00e+00 | 2.539 | 1 | 4 | 112 |
GO:0043005 | neuron projection | 1.60e-01 | 1.00e+00 | 2.526 | 1 | 6 | 113 |
GO:0000287 | magnesium ion binding | 1.63e-01 | 1.00e+00 | 2.501 | 1 | 4 | 115 |
GO:0007049 | cell cycle | 1.63e-01 | 1.00e+00 | 2.501 | 1 | 8 | 115 |
GO:0044212 | transcription regulatory region DNA binding | 1.99e-01 | 1.00e+00 | 2.187 | 1 | 13 | 143 |
GO:0001701 | in utero embryonic development | 2.12e-01 | 1.00e+00 | 2.080 | 1 | 7 | 154 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 2.21e-01 | 1.00e+00 | 2.016 | 1 | 18 | 161 |
GO:0005874 | microtubule | 2.23e-01 | 1.00e+00 | 1.998 | 1 | 10 | 163 |
GO:0016071 | mRNA metabolic process | 2.32e-01 | 1.00e+00 | 1.937 | 1 | 10 | 170 |
GO:0006412 | translation | 2.41e-01 | 1.00e+00 | 1.871 | 1 | 12 | 178 |
GO:0016567 | protein ubiquitination | 2.53e-01 | 1.00e+00 | 1.792 | 1 | 14 | 188 |
GO:0016070 | RNA metabolic process | 2.53e-01 | 1.00e+00 | 1.792 | 1 | 10 | 188 |
GO:0005743 | mitochondrial inner membrane | 2.64e-01 | 1.00e+00 | 1.724 | 1 | 9 | 197 |
GO:0019899 | enzyme binding | 2.78e-01 | 1.00e+00 | 1.632 | 1 | 7 | 210 |
GO:0006508 | proteolysis | 3.37e-01 | 1.00e+00 | 1.302 | 1 | 11 | 264 |
GO:0008285 | negative regulation of cell proliferation | 3.51e-01 | 1.00e+00 | 1.233 | 1 | 11 | 277 |
GO:0044822 | poly(A) RNA binding | 3.51e-01 | 1.00e+00 | 0.704 | 2 | 45 | 799 |
GO:0005634 | nucleus | 3.79e-01 | 1.00e+00 | 0.267 | 6 | 158 | 3246 |
GO:0000278 | mitotic cell cycle | 3.88e-01 | 1.00e+00 | 1.052 | 1 | 28 | 314 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.91e-01 | 1.00e+00 | 1.038 | 1 | 17 | 317 |
GO:0005524 | ATP binding | 4.04e-01 | 1.00e+00 | 0.546 | 2 | 37 | 892 |
GO:0005509 | calcium ion binding | 4.23e-01 | 1.00e+00 | 0.891 | 1 | 9 | 351 |
GO:0042802 | identical protein binding | 4.26e-01 | 1.00e+00 | 0.879 | 1 | 15 | 354 |
GO:0046872 | metal ion binding | 4.28e-01 | 1.00e+00 | 0.479 | 2 | 24 | 934 |
GO:0045893 | positive regulation of transcription, DNA-templated | 4.46e-01 | 1.00e+00 | 0.788 | 1 | 21 | 377 |
GO:0005515 | protein binding | 4.60e-01 | 1.00e+00 | 0.144 | 7 | 198 | 4124 |
GO:0042803 | protein homodimerization activity | 4.90e-01 | 1.00e+00 | 0.605 | 1 | 13 | 428 |
GO:0045087 | innate immune response | 5.09e-01 | 1.00e+00 | 0.526 | 1 | 12 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 5.12e-01 | 1.00e+00 | 0.514 | 1 | 29 | 456 |
GO:0005730 | nucleolus | 5.74e-01 | 1.00e+00 | 0.097 | 2 | 74 | 1217 |
GO:0005887 | integral component of plasma membrane | 5.98e-01 | 1.00e+00 | 0.179 | 1 | 8 | 575 |
GO:0007165 | signal transduction | 6.25e-01 | 1.00e+00 | 0.075 | 1 | 24 | 618 |
GO:0006355 | regulation of transcription, DNA-templated | 6.81e-01 | 1.00e+00 | -0.135 | 1 | 31 | 715 |
GO:0044281 | small molecule metabolic process | 7.43e-01 | 1.00e+00 | -0.375 | 1 | 35 | 844 |
GO:0070062 | extracellular vesicular exosome | 7.45e-01 | 1.00e+00 | -0.334 | 2 | 51 | 1641 |
GO:0003677 | DNA binding | 7.84e-01 | 1.00e+00 | -0.541 | 1 | 52 | 947 |
GO:0005886 | plasma membrane | 7.89e-01 | 1.00e+00 | -0.454 | 2 | 46 | 1784 |
GO:0016020 | membrane | 8.62e-01 | 1.00e+00 | -0.891 | 1 | 56 | 1207 |